(GENI)
NYQ – Real Time Price. Currency in USD
4.33
-0.08 (-1.81%)
At close: Mar 27, 2026, 4:00 PM EDT
4.34
+0.01 (0.18%)
After-hours: Mar 27, 2026, 6:24 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
4.33
-0.08 (-1.81%)
At close: Mar 27, 2026, 4:00 PM EDT
4.34
+0.01 (0.18%)
After-hours: Mar 27, 2026, 6:24 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.55 | 4.18 | 8.0 | |
| Quick ratio | 1.55 | 3.32 | 8.0 | |
| Debt to Equity | 0.04 | 0.21 | 9.0 | |
| Debt to Assets | 0.03 | 1.87 | 9.0 | |
| Interest coverage | -7.94 | 30.81 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 341M | 413M | 511M | 669M | 669M |
| Gross Profit | 2M | 68M | 127M | 152M | 152M |
| Operating Income | -157M | -69M | -49M | -105M | -105M |
| Net Income | -182M | -86M | -63M | -112M | -112M |
| EBITDA | -81M | 9M | 25M | -33M | -33M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 19.19 | -109.17 | 5.0 |
| Next quarter | 21.81 | 91.95 | 10 |
| Current year | 28.93 | 117.7 | 10 |
| Next year | 26.64 | 406.51 | 10 |
| Weighted average score | 8.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 44.63 | 28.43 | 27.27 | 339 | 10 |
| Y/Y | 37.01 | 26.91 | 33.33 | -0.79 | 7.8 |
| 3y average | 25.28 | 0.74 | 8.08 | 242.69 | 7.0 |
| 5y average | 36.22 | -356.31 | -408.91 | 53.57 | 5.5 |
| Weighted average score | 7.6 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $280.6M significantly exceed its total debt $30.5M, ensuring strong financial flexibility
Total current assets $548.5M exceed Total current liabilities $352.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.2), showcasing prudent financial management
Interest coverage ratio (-7.9x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $84.0M, supporting its financial health